Yongchang Sun Selected Research

Smoke

1/2023	More severe lung lesions in smoker patients with active pulmonary tuberculosis were associated with peripheral NK cell subsets.
1/2022	Dysregulated myokines and signaling pathways in skeletal muscle dysfunction in a cigarette smoke-induced model of chronic obstructive pulmonary disease.
1/2022	IL-17A Promotes Epithelial ADAM9 Expression in Cigarette Smoke-Related COPD.
1/2022	Complement component 3 protects human bronchial epithelial cells from cigarette smoke-induced oxidative stress and prevents incessant apoptosis.
1/2022	Myostatin/HIF2α-Mediated Ferroptosis is Involved in Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease.
1/2021	RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
1/2021	Muscle-Bone Crosstalk in Chronic Obstructive Pulmonary Disease.
1/2020	Cigarette smoke-induced HMGB1 translocation and release contribute to migration and NF-κB activation through inducing autophagy in lung macrophages.
1/2020	Infection of Mycobacterium tuberculosis Promotes Both M1/M2 Polarization and MMP Production in Cigarette Smoke-Exposed Macrophages.
1/2020	Role of Regulatory T Cells in Disturbed Immune Homeostasis in Patients With Chronic Obstructive Pulmonary Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongchang Sun Research Topics

Disease

31	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 12/2011
6	COVID-19 02/2024 - 01/2021
6	Asthma (Bronchial Asthma) 12/2023 - 12/2003
6	Inflammation (Inflammations) 08/2023 - 04/2015
5	Bronchiectasis 08/2023 - 07/2016
4	Tuberculosis (Tuberculoses) 10/2023 - 07/2016
4	Osteoporosis 01/2021 - 12/2011
3	Dyspnea (Shortness of Breath) 11/2023 - 10/2014
3	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 02/2012
3	Emphysema 01/2022 - 12/2011
2	Sepsis (Septicemia) 02/2023 - 01/2023
2	Disease Progression 01/2023 - 07/2021
2	Chronic Bronchitis 01/2023 - 07/2021
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 09/2019
2	Pulmonary Tuberculosis 01/2023 - 07/2016
2	Chronic Cough 11/2019 - 10/2014
2	Airway Remodeling 05/2016 - 07/2015
1	Breakthrough Infections 02/2024
1	Fat Embolism 01/2023
1	Amyloidosis 01/2023
1	Hypercapnia 01/2023
1	Cough 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Pain (Aches) 01/2022
1	Pulmonary Embolism 01/2022
1	Thrombophilia 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 04/2021
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Human Influenza (Influenza) 01/2021
1	Atrophy 01/2021
1	Sarcopenia 01/2021
1	Bone Diseases (Bone Disease) 01/2021

Drug/Important Bio-Agent (IBA)

14	SmokeIBA 01/2023 - 04/2015
8	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2016
6	CytokinesIBA 02/2024 - 03/2015
6	Interleukin-6 (Interleukin 6)IBA 02/2023 - 12/2011
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
4	VaccinesIBA 02/2024 - 01/2021
4	LipidsIBA 01/2023 - 01/2022
4	Interleukin-17 (Interleukin 17)IBA 01/2022 - 08/2016
3	Immunoglobulin E (IgE)IBA 08/2023 - 10/2014
3	MyostatinIBA 01/2022 - 01/2021
3	GoldIBA 07/2021 - 07/2016
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 12/2003
2	AntibodiesIBA 02/2024 - 04/2021
2	Biological FactorsIBA 01/2023 - 07/2021
2	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 10/2017
2	Fibrinogen (Factor I)FDA Link 01/2023 - 07/2016
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2003
2	MyokinesIBA 01/2022 - 01/2021
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2013
2	LigandsIBA 01/2020 - 08/2016
2	Oxygen (Dioxygen)IBA 09/2019 - 02/2012
2	Interleukin-8 (Interleukin 8)IBA 01/2017 - 01/2017
2	InterleukinsIBA 05/2016 - 07/2015
2	CollagenIBA 05/2016 - 07/2015
2	AllergensIBA 07/2015 - 10/2014
1	Neutralizing AntibodiesIBA 02/2024
1	COVID-19 VaccinesIBA 12/2023
1	Formoterol Fumarate (Oxis)FDA Link 11/2023
1	Antinuclear AntibodiesIBA 07/2023
1	PerforinIBA 02/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2023
1	Expectorants (Mucolytics)IBA 01/2023
1	Rheumatoid FactorIBA 01/2023
1	Congo RedIBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	AntithrombinsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	DisintegrinsIBA 01/2022
1	SolutionsIBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 01/2022
1	RivaroxabanIBA 01/2022
1	Ribosomal DNA (rDNA)IBA 01/2022
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 01/2022
1	Immunoglobulin G (IgG)IBA 04/2021
1	Gold Colloid (Colloidal Gold)IBA 04/2021
1	Immunoglobulin M (IgM)IBA 04/2021
1	Theophylline (Theon)FDA LinkGeneric 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	CalciumIBA 01/2021
1	Transient Receptor Potential ChannelsIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2021
1	Caspase 1 (ICE Protease)IBA 01/2021
1	RANK LigandIBA 01/2021
1	CationsIBA 01/2021
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2020

Therapy/Procedure

7	Therapeutics 10/2023 - 02/2012
1	Biological Therapy 12/2023
1	Critical Care (Surgical Intensive Care) 10/2023
1	Lipectomy (Liposuction) 01/2023
1	Length of Stay 01/2023